Human Brain Single-cell Genomics Explorer (U24 - Clinical Trial Not Allowed)
ID: 356696Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $1M

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/356696

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-24-038.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Human Brain Single-cell Genomics Explorer" (U24 - Clinical Trial Not Allowed) to establish an integrated resource for analyzing and sharing de-identified human brain single-cell transcriptomics and epigenomics data. The initiative aims to develop a Single Cell Genomics Explorer that provides harmonized bioinformatics tools and a unified cell-type taxonomy, enhancing usability for researchers and ensuring datasets are Findable, Accessible, Interoperable, and Reusable (FAIR). With an estimated budget of $1 million and a project duration of three years, eligible applicants include a diverse range of organizations, such as Historically Black Colleges and Universities and Tribal Colleges, among others. Interested parties should note that applications are due by February 14, 2025, and can find further details at the provided NIH grants link or by contacting grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-NS-24-038.html
    The Department of Health and Human Services, via the NIH Blueprint for Neuroscience, announces a funding opportunity (RFA-NS-24-038) for establishing an integrated resource to analyze and share de-identified human brain single-cell transcriptomics and epigenomics data. The project aims to develop a Single Cell Genomics Explorer, providing harmonized bioinformatics tools and a unified cell-type taxonomy to enhance usability for researchers. Eligible applicants include various organizations, with an estimated budget of $1 million and a project duration of three years. The initiative emphasizes collaboration with existing NIH-supported human single-cell omics data, specifically integrating at least three major datasets. Applications must adhere to strict guidelines, including the use of new forms (FORMS-I) and robust data management plans. The resource seeks to ensure datasets become Findable, Accessible, Interoperable, and Reusable (FAIR), with a focus on community engagement and feedback for ongoing refinement. The anticipated timeline for application submissions begins January 14, 2025, with potential funding decisions following thorough peer review processes.
    Similar Opportunities
    BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience," aimed at supporting the establishment of facilities at minority-serving institutions (MSIs) and Institutional Development Award (IDeA)-eligible institutions. The objective is to facilitate the scaled production and distribution of brain cell type-specific access and manipulation reagents, which are crucial for advancing neuroscience research by enabling precise probing of circuit functions in experimental animals and human tissues. This initiative is part of the BRAIN Initiative Armamentarium project, and awardees will collaborate with other researchers to manufacture and distribute various reagents, including viral vectors and nucleic acid constructs. Interested applicants can find more information and apply before the closing date of June 15, 2027, by visiting the NIH grants website or contacting NIH Grants Information at grantsinfo@nih.gov.
    BRAIN Initiative: Scaled reagent resources for brain cell type-specific access across vertebrate species (U01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the BRAIN Initiative aimed at scaling up brain cell type-specific molecular or genetic access reagents across vertebrate species. This initiative seeks to develop and validate viral, non-viral, transgenic, and gene regulatory element screening technologies to enhance neuroscience research and improve understanding of brain circuits, ultimately aiding in the treatment of brain disorders. The program anticipates a total funding of $14 million per year, with a maximum project period of five years, and encourages applications from a diverse range of eligible institutions, including historically black colleges, tribal colleges, and non-profit organizations. Interested applicants should submit their proposals by January 17, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.
    BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Notice of Funding Opportunity (NOFO) for the BRAIN Initiative, aimed at developing web-accessible data archives to capture, store, and curate data related to neuroscience research. The initiative seeks to enhance research efforts by establishing community resource data archives that adhere to high-quality data standards and improve accessibility for the research community. With an anticipated funding amount of $4 million, NIH plans to award 3-4 grants, each lasting up to five years, and applicants are required to submit a Plan for Enhancing Diverse Perspectives (PEDP) as part of their proposals. Interested parties can find more information and submit inquiries via email at grantsinfo@nih.gov, with applications due by June 24, 2026.
    Single Source: The NIGMS Human Genetic Cell Repository (U42 - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a non-competitive funding opportunity for a cooperative agreement to support the Human Genetic Cell Repository (HGCR), with a focus on maintaining and distributing a diverse collection of human cell lines and DNA samples for biomedical research. The initiative aims to enhance the repository's capacity by acquiring new cell lines from diverse populations, ensuring ethical practices in sample collection, and promoting inclusivity in research efforts. This funding opportunity provides up to $1.75 million annually for a five-year project period, with applications due by June 10, 2026. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov or visit the funding announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-055.html.
    Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting proposals for the funding opportunity titled "Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)," aimed at advancing research on the biological mechanisms underlying complex brain disorders such as schizophrenia, bipolar disorder, and autism. This initiative encourages studies that explore high-confidence risk factors associated with these disorders, focusing on intracellular, transcellular, and circuit mechanisms, while emphasizing the importance of disseminating findings to enhance data resources and therapeutic target identification. Eligible applicants include a wide range of institutions, including historically black colleges, tribal colleges, and various nonprofit organizations, with applications due by September 7, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and detailed information can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-024.html.
    BRAIN Initiative: Production and distribution facilities for brain cell type-specific access reagents (U24 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity under the BRAIN Initiative to establish Production and Distribution Facilities (PDFs) for brain cell type-specific access reagents. The initiative aims to enhance the production and dissemination of reagents, such as viral vectors and nucleic acid constructs, to facilitate collaborative research on brain function among various NIH components. This funding opportunity anticipates a total of $2.4 million annually for 2 to 4 awards, with a project period of up to 5 years, and applications must address key functions including interfacing with Research Resource for Design and Development projects, scaled-up production, broad dissemination of reagents, and coordination of data sharing. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov, with the application deadline set for July 1, 2026.
    Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)" aimed at encouraging research into high-confidence risk factors associated with complex brain disorders such as schizophrenia, bipolar disorder, and major depression. This initiative supports exploratory developmental research (R21) to identify molecular, cellular, and circuit mechanisms involved in these disorders, utilizing diverse experimental paradigms without the necessity for prior feasibility data. The funding amount is capped at $275,000 over two years, with a maximum of $200,000 per year, and eligible applicants include a wide range of educational institutions, nonprofits, and for-profit organizations. Interested parties can find more information and application details at the NIH website, with the application deadline set for September 7, 2026.
    Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)" aimed at advancing research in computational genomics, bioinformatics, and data visualization methodologies that enhance genomic science and its application to human health. This initiative seeks innovative projects that develop novel analytical tools and methodologies, with a budget limit of $275,000 for a two-year project period, focusing on scalable solutions applicable across various diseases and biological systems. The funding is particularly targeted at underrepresented entities in genomic research, including higher education institutions, nonprofits, and governmental bodies, reflecting NIH's commitment to fostering collaborative research in this critical field. Interested applicants should note that key submission dates begin on January 16, 2025, with a final expiration date of September 8, 2027, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)" aimed at supporting innovative research in computational genomics and data science. This initiative encourages applications that focus on developing novel analytical methodologies, tools, and software that can be broadly applied to enhance human health and disease understanding, with an emphasis on scalable systems for managing complex genomic data. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and tribal colleges, with a maximum budget of $500,000 per year available for projects lasting up to five years. The application submission period opens on January 6, 2025, and closes on September 7, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for the R21 Clinical Trial Not Allowed grant, aimed at advancing research into the cellular and molecular biology of complex brain disorders. This funding opportunity encourages innovative research focused on high-confidence risk factors associated with conditions such as schizophrenia, major depression, and anxiety, emphasizing hypothesis-generating studies rather than disorder modeling. The grant supports projects with budgets up to $275,000 over a two-year period, with applications due starting January 16, 2025, and a closing date of September 7, 2026. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to review the full announcement available at https://grants.nih.gov/grants/guide/pa-files/PAR-25-037.html.